Both blue-chip stocks have proven to be reliable stalwarts.
Compare NVO Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Novo Nordisk
These two companies have outperformed the market in the past year, and they are likely to continue doing so.
The Wall Street firm put big drugmakers' R&D programs through five different tests.
NVO earnings call for the period ending June 30, 2021.
The company is mainly known for its diabetes drugs but has some background in rare-disease drugs.
A new FDA-approved product with the potential to triple weight loss in obesity patients should be a huge win for the company.
This stock could be a great addition to any long-term portfolio.
Which diabetes drug maker will win this photo finish for investors?
NVO earnings call for the period ending March 31, 2021.
Considering business quality is the best way to earn growing payouts over time.